Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. 2003

N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
Trophoblastic Disease Screening and Treatment Centre, Department of Cancer Medicine, Imperial College School of Medicine at Charing Cross Hospital, London, UK.

OBJECTIVE To determine pregnancy outcome, including the rate of repeat molar pregnancy, following histologically confirmed complete or partial hydatidiform mole. METHODS Retrospective review of a large supraregional database of registrations for gestational trophoblastic disease. METHODS Supraregional Trophoblastic Disease Unit, London. METHODS Women with pregnancies affected by complete or partial hydatidiform mole registered between 1992 and 1998. METHODS All patients with a diagnosis of histologically confirmed complete or partial hydatidiform mole were identified and data on subsequent pregnancies compared between groups using comparison of proportion test. METHODS Pregnancy outcome by partial or complete mole subtype, with particular regard to risk of subsequent molar pregnancy. RESULTS Of 2578 complete moles, the subsequent pregnancy was affected by hydatidiform mole in 27 (1.9%) cases, including 22 (81%) complete moles and 5 (19%) partial moles. Of 2627 partial moles, the subsequent pregnancy was also molar in 25 (1.7%) cases, including 17 (68%) partial moles and 8 (32%) complete moles. Overall recurrence risk for molar pregnancy was 1.8% (1 in 55), or a 20-fold increase compared with the background risk. Of 27 cases with repeat complete moles, three had further complete moles, suggesting the recurrence risk following two previous complete moles is approximately 10%. There were no other significant differences in pregnancy outcome between cases with previous complete or partial hydatidiform mole and that expected in an unselected obstetric population. CONCLUSIONS Women having a pregnancy affected by a histologically confirmed complete or partial hydatidiform mole may be counselled that the risk of repeat mole in a subsequent pregnancy is about 1 in 60 and if this were to occur, the majority of cases will be of the same type of mole as the preceding pregnancy. However, >98% of women who become pregnant following a molar conception will not have a further hydatidiform mole and these pregnancies are at no increased risk of other obstetric complications.

UI MeSH Term Description Entries
D007752 Obstetric Labor, Premature Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE). Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006828 Hydatidiform Mole Trophoblastic hyperplasia associated with normal gestation, or molar pregnancy. It is characterized by the swelling of the CHORIONIC VILLI and elevated human CHORIONIC GONADOTROPIN. Hydatidiform moles or molar pregnancy may be categorized as complete or partial based on their gross morphology, histopathology, and karyotype. Molar Pregnancy,Pregnancy, Molar,Hydatid Mole,Hydatidiform Mole, Complete,Hydatidiform Mole, Partial,Complete Hydatidiform Mole,Complete Hydatidiform Moles,Hydatid Moles,Hydatidiform Moles,Hydatidiform Moles, Complete,Hydatidiform Moles, Partial,Molar Pregnancies,Mole, Complete Hydatidiform,Mole, Hydatid,Mole, Hydatidiform,Mole, Partial Hydatidiform,Moles, Complete Hydatidiform,Moles, Hydatid,Moles, Hydatidiform,Moles, Partial Hydatidiform,Partial Hydatidiform Mole,Partial Hydatidiform Moles,Pregnancies, Molar
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
June 2001, Human reproduction (Oxford, England),
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
October 2011, JPMA. The Journal of the Pakistan Medical Association,
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
April 1994, The Journal of reproductive medicine,
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
August 1989, Obstetrics and gynecology,
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
June 1986, British journal of obstetrics and gynaecology,
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
January 2023, International journal of women's health,
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
March 1994, European journal of obstetrics, gynecology, and reproductive biology,
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
December 2014, American journal of obstetrics and gynecology,
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
January 2008, Gynecologic and obstetric investigation,
N J Sebire, and R A Fisher, and M Foskett, and H Rees, and M J Seckl, and E S Newlands
January 2020, The Indian journal of medical research,
Copied contents to your clipboard!